What Are Some Examples of Peptide Inhibitors in Cancer Therapy?
Several peptide inhibitors are currently being investigated in clinical trials or have been approved for cancer therapy. For instance, Bortezomib is a peptide-based proteasome inhibitor approved for the treatment of multiple myeloma. Another example is ALRN-6924, a dual inhibitor of MDM2 and MDMX, which aims to reactivate the tumor suppressor p53 in various cancers.
